97,461 Shares in Danaher Corporation $DHR Purchased by The Manufacturers Life Insurance Company

The Manufacturers Life Insurance Company acquired a new stake in shares of Danaher Corporation (NYSE:DHRFree Report) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 97,461 shares of the conglomerate’s stock, valued at approximately $70,176,000.

Several other large investors have also bought and sold shares of DHR. Main Street Group LTD purchased a new stake in shares of Danaher during the first quarter valued at approximately $25,000. N.E.W. Advisory Services LLC purchased a new position in Danaher in the 2nd quarter worth approximately $25,000. JPL Wealth Management LLC purchased a new position in Danaher in the 3rd quarter worth approximately $25,000. WFA of San Diego LLC bought a new position in Danaher in the 2nd quarter valued at approximately $26,000. Finally, Hilton Head Capital Partners LLC purchased a new stake in Danaher during the 4th quarter valued at $27,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Stock Performance

Shares of DHR opened at $215.78 on Wednesday. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25. Danaher Corporation has a one year low of $160.93 and a one year high of $242.80. The firm has a market capitalization of $151.69 billion, a P/E ratio of 38.33, a PEG ratio of 2.68 and a beta of 0.78. The business has a fifty day moving average of $197.17 and a 200 day moving average of $192.36.

Danaher (NYSE:DHRGet Free Report) last posted its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. The company had revenue of $6.26 billion for the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.Danaher’s revenue was up 5.5% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.77 earnings per share. As a group, sell-side analysts anticipate that Danaher Corporation will post 8.53 EPS for the current year.

Wall Street Analyst Weigh In

A number of research firms have commented on DHR. TD Cowen reduced their target price on Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a report on Wednesday, July 22nd. Guggenheim lowered their price target on Danaher from $235.00 to $200.00 and set a “buy” rating on the stock in a report on Wednesday, July 22nd. Wells Fargo & Company dropped their price objective on Danaher from $212.00 to $195.00 and set an “equal weight” rating on the stock in a research report on Wednesday, July 22nd. HSBC reduced their price objective on Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a report on Wednesday, June 3rd. Finally, Royal Bank Of Canada upped their target price on shares of Danaher from $200.00 to $215.00 and gave the company an “outperform” rating in a research note on Wednesday, July 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $228.91.

Read Our Latest Analysis on DHR

About Danaher

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Recommended Stories

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.